Keyword: diseases

cable and satellite TV California Canada cannabis cap-and-trade capital capital allocation capital budgeting capital flows capital formation capital income capital markets capital outflows capital regulation capital requirements capital stock capitalism CAPM carbon emissions carbon leakage carbon prices carbon tax carbon taxes careers CARES Act cash central bank independence central banks charitable deductions charity charter schools chief executives childrearing children China Christmas climate change climate policies climate policy climate targets clusters college admissions college athletes college tuition commercial banks commercial property commodity markets communism competition competition policy competitiveness concentration congestion congestion charges congestion pricing Congress Congressional Budget Office Connecticut constitutional amendment consumer price index consumer prices consumer protection consumer welfare consumption consumption insurance contraception conventions coronabonds Coronavirus corporate boards corporate executives corporate investment corporate performance corporate reporting corporate reproting corporate social responsibility corporate tax corporate taxes cost disease cost of capital cost of living cost-benefit analysis costs of living Council of Economic Advisors COVID-19 credibility revolution credit credit cards credit risk creditors crime crypto assets cryptocurrencies cryptocurrency Cuba culture currencies currency currency manipulation currency reserves
Europe

Vaccines in Europe

This week's European Economic Experts Panel statements: A) Offering substantially higher prices per dose would have resulted in larger capacity investments by vaccine makers and accelerated distribution in Europe significantly. B) In the current situation, paying for more production capacity would be better than offering higher prices for vaccines. C) If the EU started paying prices above 100 euros per dose, it would on net reduce the cost of the pandemic to the EU via more lives saved and shorter lockdowns.
US

Vaccines

This week’s IGM Economic Experts Panel statement: A) Declining to be vaccinated against contagious diseases such as measles imposes costs on other people, which is a negative externality. B) Considering the costs of restricting free choice, and the share of people in the US who choose not to vaccinate their children for measles, the social benefit of mandating measles vaccines for all Americans (except those with compelling medical reasons) would exceed the social cost.